Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Neoleukin Therapeutics stock
Learn how to easily invest in Neoleukin Therapeutics stock.
Neoleukin Therapeutics is a drug manufacturers-specialty & generic business based in the US. Neoleukin Therapeutics shares (NLTX) are listed on the NASDAQ and all prices are listed in US Dollars. Neoleukin Therapeutics employs 77 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Neoleukin Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NLTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Neoleukin Therapeutics stock price (NASDAQ: NLTX)Use our graph to track the performance of NLTX stocks over time.
Neoleukin Therapeutics shares at a glance
|Latest market close||$0.62|
|52-week range||$0.38 - $3.40|
|50-day moving average||$0.49|
|200-day moving average||$0.85|
|Wall St. target price||$1.30|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.11|
Buy Neoleukin Therapeutics stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Neoleukin Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Neoleukin Therapeutics price performance over time
|1 week (2023-01-31)||4.20%|
|1 month (2023-01-06)||18.55%|
|3 months (2022-11-07)||13.97%|
|6 months (2022-08-05)||-40.95%|
|1 year (2022-02-07)||-81.10%|
|2 years (2021-02-05)||-95.54%|
|3 years (2020-02-07)||13.52|
|5 years (2018-02-07)||13.62|
Neoleukin Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-24.8%|
|Return on equity TTM||-45.51%|
|Market capitalisation||$25.3 million|
TTM: trailing 12 months
Neoleukin Therapeutics share dividends
We're not expecting Neoleukin Therapeutics to pay a dividend over the next 12 months.
Neoleukin Therapeutics share price volatility
Over the last 12 months, Neoleukin Therapeutics's shares have ranged in value from as little as $0.375 up to $3.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neoleukin Therapeutics's is 1.0837. This would suggest that Neoleukin Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Neoleukin Therapeutics overview
Neoleukin Therapeutics, Inc. , a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc.
Frequently asked questionsWhat percentage of Neoleukin Therapeutics is owned by insiders or institutions?
Currently 21.416% of Neoleukin Therapeutics shares are held by insiders and 49.762% by institutions. How many people work for Neoleukin Therapeutics?
Latest data suggests 77 work at Neoleukin Therapeutics. When does the fiscal year end for Neoleukin Therapeutics?
Neoleukin Therapeutics's fiscal year ends in December. Where is Neoleukin Therapeutics based?
Neoleukin Therapeutics's address is: 188 East Blaine Street, Seattle, WA, United States, 98102 What is Neoleukin Therapeutics's ISIN number?
Neoleukin Therapeutics's international securities identification number is: US64049K1043 What is Neoleukin Therapeutics's CUSIP number?
Neoleukin Therapeutics's Committee on Uniform Securities Identification Procedures number is: 64049K104
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert